Conditionally Replicating Adenovirus pPE3-SEA Expressing Staphylococcal Enterotoxin A (SEA) Gene for Anti-Tumor Therapies

Strategic Insights -

Researchers from Xuzhou Medical College in the People's Republic of China have successfully constructed a conditionally replicating adenovirus pPE3-SEA that expresses the staphylococcal enterotoxin A (SEA) gene. This adenovirus vector can be used for experimental studies of tumor-targeted therapies. The study aimed to evaluate the construction and characterization of the pPE3-SEA vector, which has potential applications in anti-tumor therapies.

Key Takeaways:

  • The study successfully constructed a conditionally replicating adenovirus pPE3-SEA that expresses the SEA gene.
  • The pENTR12-SEA plasmid was co-transfected into HEK293 cells along with pPE3-ccdB to generate the recombinant adenovirus pPE3-SEA vector.
  • The viral titer was determined using the 50% tissue culture infective dose method, resulting in a titer of 2.5 x 1010 pfu/ml.
  • PCR, restriction enzyme digestion, and sequence analyses proved the successful construction of the recombinant adenovirus pPE3-SEA.
  • The study demonstrated the potential of the pPE3-SEA vector for use in experimental studies of tumor-targeted therapies.
  • The researchers developed a recombinant adenovirus that can express the SEA gene, which has potential applications in anti-tumor therapies.
  • The study demonstrates the feasibility of using adenovirus vectors for cancer therapy.

Statistics:

  • The viral titer of the pPE3-SEA vector was 2.5 x 1010 pfu/ml.
  • The 50% tissue culture infective dose method was used to determine the viral titer, indicating the efficacy of the adenovirus vector.

Sources:

  • Construction of conditionally replicating adenovirus expressing staphylococcal enterotoxin A gene: potential usefulness for anti-tumor therapies. European Review for Medical and Pharmacological Sciences, 2014;18(16):2258-63.